Sentinel Therapeutics, Inc.

Sentinel is a clinical stage company developing a patented immunotherapy as a non-surgical alternative to treat skin cancer (BCC, melanoma).

  • Stage Product In Development
  • Industry Biotechnology
  • Location Vancouver, WA, USA
  • Currency USD
  • Founded September 2012
  • Website sentineltx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free